AG00H8QM

95635-55-5 | N-(2,6-dimethylphenyl)-2-{4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]piperazin-1-yl}acetamide

95635-55-5
AG00H8QM
sdsSDS
sdsCOA

Price

$0.00

WARNING This product is not for human or veterinary use.
Request For Quotation
CAS Number 95635-55-5
Catalog Number AG00H8QM(AGN-PC-0WAE7I)
Chemical Name N-(2,6-dimethylphenyl)-2-{4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]piperazin-1-yl}acetamide
IUPAC Name N-(2,6-dimethylphenyl)-2-[4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]piperazin-1-yl]acetamide
InChI InChI=1S/C24H33N3O4/c1-18-7-6-8-19(2)24(18)25-23(29)16-27-13-11-26(12-14-27)15-20(28)17-31-22-10-5-4-9-21(22)30-3/h4-10,20,28H,11-17H2,1-3H3,(H,25,29)
InChI Key XKLMZUWKNUAPSZ-UHFFFAOYSA-N
MDL Number MFCD00864690
Molecular Formula C24H33N3O4
Molecular Weight 427.5365
NSC Number 759100
SMILES C1=C(C(=CC=C1)OC)OCC(CN3CCN(CC(NC2=C(C=CC=C2C)C)=O)CC3)O
Synonyms
43285, RS, Dihydrochloride, Ranolazine, HCl, Ranolazine, Hydrochloride, Ranolazine, N-(2,6-dimethylphenyl)-4-(2-hydroxy-3-(2-methoxyphenoxy)propyl)-1-piperazineacetamide, Ranexa, ranolazine, Ranolazine Dihydrochloride, Ranolazine HCl, Ranolazine Hydrochloride, renolazine, RS 43285, RS 43285 193, RS 43285-193, RS 43285193, RS-43285, RS43285, RANOLAZINE, 95635-55-5, Ranexa, N-(2,6-dimethylphenyl)-2-(4-(2-hydroxy-3-(2-methoxyphenoxy)propyl)piperazin-1-yl)acetamide, CVT-303, (-)-Ranolazine, Ranolazine (Ranexa), RS-43285-003, N-(2,6-dimethylphenyl)-2-[4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]piperazin-1-yl]acetamide, 142387-99-3, CHEBI:87690, N-(2,6-dimethylphenyl)-2-{4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]piperazin-1-yl}acetamide, CVT 303, C24H33N3O4, NCGC00015897-02, DSSTox_CID_25196, DSSTox_RID_80743, DSSTox_GSID_45196, Ran4, Latixa, RAN D, N-(2,6-dimethylphenyl)-4-(2-hydroxy-3-(2-methoxyphenoxy)propyl)-1-piperazineacetamide, N-(2,6-DIMETHYLPHENYL)-4-[2-HYDROXY-3-(2-METHOXYPHENOXY)PROPYL]-1-PIPERAZINEACETAMIDE, (+-)-Ranolazine, CAS-95635-55-5, Ranexa (TN), SR-01000076216, Ranolazine (USAN/INN), Ranolazine [USAN:INN:BAN], HSDB 7924, 1-Piperazineacetamide, N-(2,6-dimethylphenyl)-4-(2-hydroxy-3-(2-methoxyphenoxy)propyl)-, 1-Piperazineacetamide, N-(2,6-dimethylphenyl)-4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]-, Ranolazine(Ranexa), KEG-1295, (+/-)-Ranolazine, AC1Q5LYD, CHEMBL1404, Lopac0_001062, BSPBio_002276, MLS002154149, SCHEMBL124665, SPECTRUM1505366, AC1L1M17, GTPL7291, DTXSID3045196, CTK3I7295, XKLMZUWKNUAPSZ-UHFFFAOYSA-N, HMS1922F16, HMS2090L09, HMS2093D21, HMS2098K06, HMS2230C19, HMS3369I08, HMS3655M12, HMS3715K06, Pharmakon1600-01505366, ACT06286, BCP04190, HY-B0280, KS-00000JS7, Tox21_110258, BDBM50173335, CR0012, MFCD00864690, NSC759100, s1799, AKOS015889500, Tox21_110258_1, AC-1673, AN-5494, BCP9000558, CCG-205139, CS-2292, DB00243, KS-1244, MCULE-8182023610, NSC-759100, PB21724, SB13209, NCGC00015897-03, NCGC00015897-04, NCGC00015897-05, NCGC00015897-06, NCGC00015897-08, NCGC00095177-01, NCGC00095177-02, NCGC00095177-03, 4CA-1078, AK-72950, BC205445, BR-72950, H959, SC-25810, SMR000857382, BCP0726000090, SBI-0051032.P002, AB0007809, AB2000299, LS-187267, TR-031802, FT-0601594, ST24025536, SW197620-4, CVT 303;RS 43285-003, D05700, RS 43285-003, S-1794, AB00698532-11, AB00698532-13, AB00698532-14, AB00698532-15, AB00698532_16, AB00698532_17, AB00698532_18, 635R555, I01-2008, I06-0160, SR-01000076216-5, SR-01000076216-8, BRD-A97674275-001-01-9, BRD-A97674275-001-04-3, Z68563450, (+/-)-4-(2-Hydroxy-3-(o-methoxyphenoxy)propyl)-1-piperazineaceto-2',6'-xylidide, (+-)-N-(2,6-Dimethylphenyl)-4-(2-hydroxy-3-(2-methoxyphenoxy)propyl)-1-piperazineacetamide, (+/-)-1-(3-(2-Methoxyphenoxy)-2-hydroxypropyl)-4-(n-(2,6-dimethylphenyl)carbamoylmethyl)piperazine, 1-[3-(2-methoxyphenoxy)-2-hydroxypropyl]-4-[(2,6-dimethylphenyl)aminocarbonylmethyl]piperazine, 1-Piperazineacetamide, N-(2,6-dimethylphenyl)-4-(2-hydroxy-3-(2-methoxyphenoxy)propyl)-, (+-)-, 110445-25-5, N-(2,6-Dimethyl-phenyl)-2-{4-[2-hydroxy-3-(2-methoxy-phenoxy)-propyl]-piperazin-1-yl}-acetamide, N-(2,6-dimethylphenyl)-2-{4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]piperazin-1-yl}ethanimidic acid, Ranolazine 2HCl, Ranolazine dihydrochloride, metoprolol, renexa, renolazine, Ranolazine HCl, Ranolazine 1g, Ranolazine-d3, Ranexa, Ranolazine, ( -)-Ranolazine, Ranolazine [USAN], Ranolazine hydrochloride, UNII-A6IEZ5M406, D03HYQ, D06TES, A6IEZ5M406, RS-43285, CID56959, sodium 3,5-dicarboxybenzenesulfonate, C24-H33-N3-O4, CS-T-41527, RS 43285, 2451B, Ranolazine/Dronedarone Fixed-Dose Combination, A11162, RS 43285-193, C055512, 95635-56-6, (+-)-4-[2-hydroxy-3-(o-methoxyphenoxy)propyl]-1-piperazineaceto-2',6'-xylidide, 37350-58-6,

Product Recommendations

CERTIFICATE OF ANALYSIS
Chemical Name: Batch Number:
Chemical Structure: CAS Registry No:
Product ID:
Manufacture Date:
Storage Temperature:
Formula:
Molecular Weight:
Quantity:
Analysis Data:
Test: Result:
Conclusion: The above product meets the specifications of Angene.
Analyst:Chase
Date:
Reviewed by:Jessie
Date:
Angene International Limited